ARRY @ Goldman Sachs Global Healthcare Conference

Array Biopharma To Present At The Goldman Sachs 38th Annual Global Healthcare Conference

BOULDER, Colo., June 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the Goldman Sachs 38th Annual Global Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   
Event: 

Goldman Sachs 38th Annual Global Healthcare Conference

Presenter: 

Andy Robbins, Chief Operating Officer

Date: 

Tuesday, June 13, 2017

Time: 

10:00 a.m. Pacific Time

Webcast: 

cc.talkpoint.com/gold006/061317a_as/?entity=52_O16UKUL




About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Array-owned or partnered drugs are advancing in registration studies: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), larotrectinib (partnered with Loxo Oncology), tucatinib (partnered with Cascadian Therapeutics) and ipatasertib (partnered with Roche).
CONTACT:

Tricia Haugeto



Array BioPharma Inc.



303-386-1193



thaugeto@arraybiopharma.com